159 related articles for article (PubMed ID: 12397365)
1. Olprinone: a phosphodiesterase III inhibitor with positive inotropic and vasodilator effects.
Mizushige K; Ueda T; Yukiiri K; Suzuki H
Cardiovasc Drug Rev; 2002; 20(3):163-74. PubMed ID: 12397365
[TBL] [Abstract][Full Text] [Related]
2. The effects of olprinone, a phosphodiesterase 3 inhibitor, on systemic and cerebral circulation.
Ueda T; Mizushige K
Curr Vasc Pharmacol; 2006 Jan; 4(1):1-7. PubMed ID: 16472171
[TBL] [Abstract][Full Text] [Related]
3. Differential vasodilation response to olprinone in rabbit renal and common carotid arteries.
Minonishi T; Ogawa K; Tokinaga Y; Negoro T; Kimoto Y; Hatano Y
J Anesth; 2010 Feb; 24(1):61-6. PubMed ID: 20175287
[TBL] [Abstract][Full Text] [Related]
4. Effect of olprinone, a phosphodiesterase III inhibitor, on balance of cerebral oxygen supply and demand during cardiopulmonary bypass.
Yamanaka H; Hayashi Y; Kamibayashi T; Mashimo T
J Cardiovasc Pharmacol; 2011 May; 57(5):579-83. PubMed ID: 21326107
[TBL] [Abstract][Full Text] [Related]
5. Possible mechanisms underlying the vasodilatation induced by olprinone, a phosphodiesterase III inhibitor, in rabbit coronary artery.
Ohashi M; Dohi Y; Itoh T
Br J Pharmacol; 2000 Mar; 129(5):1000-6. PubMed ID: 10696101
[TBL] [Abstract][Full Text] [Related]
6. Effect of olprinone, phosphodiesterase III inhibitor, on cerebral blood flow assessed with technetium-99m-ECD SPECT.
Yu Y; Mizushige K; Ueda T; Nishiyama Y; Seki M; Aoyama T; Ohkawa M; Matsuo H
J Cardiovasc Pharmacol; 2000 Mar; 35(3):422-6. PubMed ID: 10710128
[TBL] [Abstract][Full Text] [Related]
7. The effects of olprinone (a phosphodiesterase III inhibitor) on hepatic vascular bed in a porcine model of endotoxemia.
Nagata E; Kakihana Y; Tobo K; Isowaki S; Kanmura Y
Anesth Analg; 2001 Mar; 92(3):676-80. PubMed ID: 11226100
[TBL] [Abstract][Full Text] [Related]
8. Effect of olprinone, a phosphodiesterase III inhibitor, on arterial wall distensibility: differentiation between aorta and common carotid artery.
Seki M; Mizushige K; Ueda T; Kitadai M; Matsuo H
Heart Vessels; 1999; 14(5):224-31. PubMed ID: 10830918
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic effects of phosphodiesterase III inhibitor in patients with a large ventricular left-to-right shunt.
Momoi N; Sato M; Sato K; Sato T; Kobayashi T; Suzuki H; Suzuki H
Jpn Circ J; 2000 Apr; 64(4):249-53. PubMed ID: 10783045
[TBL] [Abstract][Full Text] [Related]
10. The cerebrovascular dilatation effects of olprinone, a phosphodiesterase III inhibitor, in comparison with acetazolamide--a pilot study.
Ueda T; Mizushige K; Yukiiri K; Nishiyama Y; Kohno M
Clin Neurol Neurosurg; 2004 Sep; 106(4):284-8. PubMed ID: 15297001
[TBL] [Abstract][Full Text] [Related]
11. Vasorelaxant effect of a phosphodiesterase 3 inhibitor, olprinone, on isolated human radial artery.
Adachi H; Kamata S; Kodama K; Nagakura T
Eur J Pharmacol; 2000 May; 396(1):43-7. PubMed ID: 10822053
[TBL] [Abstract][Full Text] [Related]
12. The effects of the phosphodiesterase inhibitor olprinone on global cerebral ischemia.
Okayama N; Matsunaga A; Kakihana Y; Fujikawa K; Inoue K; Nagayama T; Takeyama M; Miyata A; Kanmura Y
Anesth Analg; 2010 Mar; 110(3):888-94. PubMed ID: 20042441
[TBL] [Abstract][Full Text] [Related]
13. Effect of phosphodiesterase III inhibitor on contractility, afterload, and vascular capacitance during right heart bypass preparation.
Tanoue Y; Morita S; Nagano I; Ochiai Y; Tominaga R; Kawachi Y; Yasui H
Jpn J Thorac Cardiovasc Surg; 2001 Oct; 49(10):607-13. PubMed ID: 11692586
[TBL] [Abstract][Full Text] [Related]
14. Olprinone, a phosphodiesterase III inhibitor, does not affect hypoxia-induced pial arteriolar dilatation in rabbits.
Miyabe M; Tajima K; Takahashi H; Toyooka H
Can J Anaesth; 2003 Feb; 50(2):193-7. PubMed ID: 12560314
[TBL] [Abstract][Full Text] [Related]
15. Effects of olprinone on myocardial ischemia-reperfusion injury in dogs.
Setoyama K; Kamimura R; Fujiki M; Misumi K; Miyahara K; Sakamoto H
J Vet Med Sci; 2006 Aug; 68(8):865-8. PubMed ID: 16953089
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of olprinone after cerebral ischemia/reperfusion injury in rats.
Genovese T; Mazzon E; Paterniti I; Esposito E; Cuzzocrea S
Neurosci Lett; 2011 Oct; 503(2):93-9. PubMed ID: 21872644
[TBL] [Abstract][Full Text] [Related]
17. Effects of olprinone, a new phosphodiesterase inhibitor, on gastric intramucosal acidosis and systemic inflammatory responses following hypothermic cardiopulmonary bypass.
Yamaura K; Akiyoshi K; Irita K; Taniyama T; Takahashi S
Acta Anaesthesiol Scand; 2001 Apr; 45(4):427-34. PubMed ID: 11300380
[TBL] [Abstract][Full Text] [Related]
18. [Effects of amrinone on renal blood flow and cardiac function, in comparison with those of milrinone and olprinone, in anesthetized dog].
Fujishima K; Yamamoto A; Hachisu M
Nihon Yakurigaku Zasshi; 1998 Dec; 112(6):371-80. PubMed ID: 10202762
[TBL] [Abstract][Full Text] [Related]
19. Vasorelaxant effect of olprinone, an inhibitor of phosphodiesterase 3, on mesenteric small artery and vein of rabbits.
Fujimoto S; Ohashi M; Hiramoto A; Inoue Y; Nagai K; Shiokawa H; Itoh T
Eur J Pharmacol; 1998 Jul; 353(2-3):239-46. PubMed ID: 9726653
[TBL] [Abstract][Full Text] [Related]
20. Effects of olprinone, a phosphodiesterase III inhibitor, on ischemic acute renal failure.
Anas C; Ozaki T; Maruyama S; Yamamoto T; Zu Gotoh M; Ono Y; Matsuo S
Int J Urol; 2007 Mar; 14(3):219-25. PubMed ID: 17430259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
